Publication | Closed Access

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

Androgen-deprivation TherapyUrologyGenitourinary CancerMedicineGetug-afu 15PharmacotherapyProstatic DiseaseOncologyRadiation OncologyEndocrine-related Cancer